Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 72471

20 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 20, 2015
Product types
Device
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Ameditech Inc

Dossier provenance

Source snapshots represented here

  • openFDA Device Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
  • openFDA Device Recall event_date_initiated coverage June 01, 1997–June 30, 2026

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

20 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

device · product 1 of 20

1 Step 12 Panel Cup, Item No. NBCA-12M-W These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0298-2016
Recall number
Z-0298-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
787 kits

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

144408 150675

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 2 of 20

10-Panel Pipette Drug Screen, Item No. PSP-10M These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0299-2016
Recall number
Z-0299-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
200 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

133930 143597

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 3 of 20

11 Panel Cup (OPI2000) w/Adult, Item No. 71125AA2K ; and 11 Panel Cup (OPI300) w/Adult, Item No. 71125AA These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0300-2016
Recall number
Z-0300-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
100 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

150503 144376

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 4 of 20

11 Panel Dip Card (OPI 2000), Item No. 11125AA2K; 11 Panel Dip Card (OPI 300) w/Adult, Item No. 11125AA These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0301-2016
Recall number
Z-0301-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
150 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

142898 151145 142899

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 5 of 20

12-Panel Dip Drug Screen with adulterant, Item No. PSDA-12BUP These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0302-2016
Recall number
Z-0302-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
960 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

144302 150323 150661 151143 151467

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 6 of 20

ArcPoint Labs 10 Panel Dip Screen (OXY), Item No. APD-10MO These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0303-2016
Recall number
Z-0303-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
320 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

141001

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 7 of 20

CLIA RDTC 12-Panel Cup and CLIA RDTC 12-Panel Cup (w/Adulteration), Item No. CLIA-RDTC-12 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0304-2016
Recall number
Z-0304-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
7,482 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

142320 143666 143753 144217 144414 144439 144454 144510 144952

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 8 of 20

DrugCheck Pipette 10 Drug Test, Item No. 41025 DC These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0305-2016
Recall number
Z-0305-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
70 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

142512

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 9 of 20

DrugCheck Waived 12 Panel Cup w/Adult, Item No. DCC-81205-5 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0306-2016
Recall number
Z-0306-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
1104 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

144216 150546 150746

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 10 of 20

DrugSmart 10 Test Cup (PCP & MDMA), Item No. 61055D; DrugSmart 10 Test Cup (PCP & OXY), Item No. 61020D These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0307-2016
Recall number
Z-0307-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
300 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

142293 151047 151233

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 11 of 20

DrugSmart 11 Test Cup, Item No. 61127D; DrugSmart 12 Test Cup (Multi & BUP), Item No. 61210D; DrugSmart 9 Test Cup (BUP), Item No. 60960D; DrugSmart Cup 10, Item No. 61093D-3C These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0308-2016
Recall number
Z-0308-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
1220 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

140770 142294 151050 151527 142527 140998 142526 150596 151122 151196

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 12 of 20

DrugSmart Dip (MET/OPI2)+AMP+BZO+COC+THC, Item No. 30600D; DrugSmart Dip AMP/OPI2/COC/THC/BZO Test, Item No. 30520D These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0309-2016
Recall number
Z-0309-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
160 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

141379 144260 150225

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 13 of 20

EDI BZO UNCUT SHEET-CARD, Item No. 100170 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use.

Z-0310-2016
Recall number
Z-0310-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
70364 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

134268 134898 140206 140218 140453 140551 141053 141129 143471 143553 144468 144557 150317 150531 150606 150638 150834 151154 152021 152104 134067 134504 140495 141010 141128 141197 143716 143784 143866 144003 144042 144199 144270 144332 144443 144502 144555 150237 150347 150440 150901 150989 151239 151925 151984 152003 152103

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 14 of 20

iCup Drug Screen Cup, Item No. I-DXA-187-016, I-DXA-167-013; iCup DX 10 Panel w/Adulterant, Item No. I-DXA-1107-142; iCup DX 11 Panel w/Adulterant, Item No. I-DXA-1117-131; iCup DX 12 Panel w/Adulterant, Item No. I-DXA-1127-023; iCup DX 6 Panel w/Adulterant, Item No. I-DXA-167-013; iCup DX 8 Panel w/Adulterant, Item No. I-DXA-187-016; iCup DX Drug Screen, Item No. I-DXA-1127-023 These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Z-0311-2016
Recall number
Z-0311-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
27,638 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

141210 141425 141561 141870 141994 142126 143608 144152 144218 145067 150105 150167 151215 150976 141844 141929 142258 142314 143606 144511 145058 145059 150549 150867 150919 150920 151179 151190 151255 151338 151476 144377 150101 150285 150420 151161 151399 151696 144209 144463 150018 150107 150690 150883 141492 141519 141552 141726

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 15 of 20

Immutest 10 Pnl Drug Screen Cup w/ Adult, Item No. IMCA-10M5; Immutest 11 Pnl Drug Screen Cup w/ Adult, Item No. IMCA-11OP; Immutest 12 Panel Cup w/Adulteration, Item No. IMCA-12BUP; Immutest 5 panel, Item No. IMCA-5AB-W; Immutest 5 Pnl Drug Cup w/ Adult -waived, Item No. IMCA-5AB-W; Immutest 7 panel, Item No. IMCA-7P; ImmuTest Cup 7-panel w/ Adulteration, Item No. IMCA-7P These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Z-0312-2016
Recall number
Z-0312-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
1172 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

144380 144564 150505 150908 151538 142098 144103 150313 150909 141645 144563 150483 151337 142076 142966 144263 151540

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 16 of 20

Micro Screen 6 Panel Cup with Adult (AU), Item No. MSCA-6MBAU These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Z-0313-2016
Recall number
Z-0313-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
3574 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

G140435 G140436 G150005 G150016 G150030 G150083 G150125

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 17 of 20

Premier Clia Waived 12 panel Tilt Cup, Item No. C12APC These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Z-0314-2016
Recall number
Z-0314-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
384 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

141748

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 18 of 20

ProScreen 10 Drug Panel Cassette Test, Item No. CPSP-10PPX; ProScreen 10 Panel Cup, Item No. PSCup-10MMO-300, PSCup-10M, PSCupA-10MO, PSCUp-10AB; ProScreen 10 Panel Cup with Adulterants, Item No. PSCupA-10AM; ProScreen 10 Panel Dip Card, Item No. PSD-10MMO-300, PSD-10MOX, PSD-10M, PSD-10CMO3, PSD-10APO-300; ProScreen 10 Panel Dip Card w/Adult, Item No. PSDA-10MO, PSDA-10MMO-300; ProScreen 11 Panel Dip Card, Item No. PSD-11MT; ProScreen 12 Drug Cup w/Adulteration, Item No. PSCupA-12TBU; ProScreen 12 Panel Cup w/Adult., Item No. PSCupA-12M, PSCupA-12PP; ProScreen 12 Panel Dip Card, Item No. PSD-12BUP ProScreen 5 Panel Dip Card, Item No. PSD-5MB; ProScreen 5 Panel Dip Card w/Adult, Item No. PSDA-5MB-300; ProScreen 6 Panel Cassette w/Adult (AU), Item No. PSPA-6MBAU; ProScreen 6 Panel Cup w/Adult (AU), Item No. PSCupA-6MBAU; ProScreen 6 Panel Dip Card, Item No. PSD-6MBO, PSD-6MTDBO-300, PSD-6MB, PSD-6BUPO; ProScreen 7 Panel Dip Card, Item No. PSD-7MO, PSD-7M; ProScreen 8 Panel Dip Card, Item No. PSD-8P; ProScreen 8 Panel Dip Card w/Adult, Item No. PSDA-8P; ProScreen 9 Panel Dip Card, Item No. PSD-9P; ProScreen CLIA Waived Cup 6 Drugs w/Adul, Item No. PSCupA-6MB-W; ProScreen CLIA Waived Cup with 6 Drugs, Item No. PSCup-6BO-W; ProScreen CLIA Waived Cup with 8 Drug, Item No. PSCup-8P-W; ProScreen Cup, Item No. PSCup-6MB-W, PSCupA-6MB-W, PSCup-6BO-W, PSCup-8P-W, PSCUp-10AB, PSCup-10MMO-300; ProScreen Cup CLIA with 6 Panel Drug, Item No. PSCup-6MB-W; These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Z-0315-2016
Recall number
Z-0315-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
31,530 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

134545 150270 150542 134346 134347 141739 141836 141841 142565 142951 143151 143875 144102 144106 144239 144241 144362 150192 150198 150629 150630 150651 150791 150959 151037 151358 151359 143402 143813 144240 151395 134181 141028 141458 142039 142111 142385 142396 142498 142717 142823 142957 142972 143514 143828 144298 144301 144308 144309 144310 144519 144520 144540 144541 150087 150108 150145 150169 150514 150516 150639 150810 151018 151523 151524 143574 143947 145055 150037 150187 150310 150457 150660 150881 150941 151465 151468 142864 150051 150512 141889 144364 150792 141747 142054 144104 144363 150689 151066 151067 142284 150208 150509 150643 150936 140904 141374 141527 141746 144261 144537 151282 151295 144336 150879 G150042 G140426 G150017 G150048 G150069 G150111 G150146 140905 140906 141014 141027 141225 141228 141347 141440 141446 141510 141740 141742 141751 144334 144335 144539 144545 144546 150148 150154 150168 150232 150462 150478 150601 150602 150653 150808 150938 151283 142514 143150 143404 143858 144394 144440 150482 150513 150904 151372 142528 143154 143405 150339 151297 150050 142529 142971 143155 143474 144547 150286 150654 150786 143803 150003 150207 150828 143874 144562 150182 150231 150325 141296 141372 141475 141476 141583 141842 143825 144227

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 19 of 20

The Drug Detection Agency 6 Panel Cup Body and Lid w/Adult (AU), Item No. TDDA-6MBAU-CUP These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Z-0316-2016
Recall number
Z-0316-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
2,240 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

G140422-C G150059-C G150063-C G150132-C

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.

device · product 20 of 20

THERMO FISHER 6 DRUG CASSETTE, Item No. MTPA-6MBAU, MTPA-8MBAU These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. ¿¿¿

Z-0317-2016
Recall number
Z-0317-2016
Initiated
October 20, 2015
Classification
Class II
Status
Terminated
Recalling firm
Ameditech Inc
Quantity
220 units

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

These labels are deterministic app interpretations, not FDA categories.

Official device-enrichment evidence · Sourced

Nonconforming Material/Component

Compare all device evidence states

Inspect official wording and provenance

Reason for recall

Ameditech is recalling drug abuse tests because they have shown reduced reactivity.

Code information

G150094 G150136

Distribution pattern

Worldwide Distribution - US (nationwide) and Internationally to Australia.